Vascular Imaging With Ferumoxytol as a Contrast Agent.
Vascular Imaging With Ferumoxytol as a Contrast Agent.
复制标题
DOI：
10.2214/ajr.15.14534
复制
发表时间：
2015-09
期刊：
影响因子：
--
通讯作者：
Saloner D
中科院分区：
文献类型：
--
作者：
Hope MD;Hope TA;Zhu C;Faraji F;Haraldsson H;Ordovas KG;Saloner D
阿魏木糖醇越来越多地被报道为磁共振血管造影（MRA）中钆基造影剂的替代品，特别是肾衰竭患者。这篇文章总结了超过3年的临床经验，阿魏木糖醇增强MRA对一系列适应症和解剖区域。阿鲁莫西酚增强的MRA有许多优点，包括它对肾功能衰竭患者是安全的，并且作为血池剂提供了较长的血管信号平台，允许更长的导航MRA序列。
Ferumoxytol is increasingly reported as an alternative to gadolinium-based contrast agents for MR angiography (MRA), particularly for patients with renal failure. This article summarizes more than 3 years of clinical experience with ferumoxytol-enhanced MRA for a range of indications and anatomic regions. Ferumoxytol-enhanced MRA has many advantages including that it is safe for patients with renal failure and provides a lengthy plateau of vascular signal as a blood pool agent that allows longer navigated MRA sequences.